US HB7823 | 2023-2024 | 118th Congress

Status

Spectrum: Partisan Bill (Republican 12-0)
Status: Introduced on March 26 2024 - 25% progression
Action: 2024-03-29 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]

Summary

To amend the Federal Food, Drug, and Cosmetic Act to require a warning label advising that the effects of mifepristone can be counteracted, to amend the Public Health Service Act to establish a hotline to provide information to women seeking to counteract the effects of mifepristone, and for other purposes.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Second Chance for Moms Act

Sponsors


History

DateChamberAction
2024-03-29HouseReferred to the Subcommittee on Health.
2024-03-26HouseReferred to the House Committee on Energy and Commerce.
2024-03-26HouseIntroduced in House

Subjects


US Congress State Sources


Bill Comments

feedback